Studies on the anti-diabetic and hypolipidemic potentials of mangiferin (xanthone glucoside) in streptozotocin-induced type 1 and type 2 diabetic model rats

International Journal of Advances in Pharmaceutical Sciences

Volumn 1, Issue 1, 2010, Pages 75-85

  Dineshkumar, B ^a   Mitra, Analava ^a   Manjunatha, M ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Anti diabetic; Hypolipidemic; Mangiferin; Type 2 diabetes

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; AMYLASE; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MANGIFERIN; RECOMBINANT HUMAN INSULIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; IC 50; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79952010158     PISSN: None     EISSN: 09761055     Source Type: Journal    
DOI: 10.5138/ijaps.2010.0976.1055.01009     Document Type: Article

References (30)

1. Wild S, Rolglic G, Green A, Sicress R, King H. Global Prevalence of Diabetes. Diabetes Care 2004;27: 1047-1053.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31: S55-S60.
3. Mitra A. Effects of Composite of tulsi leaves, amla, bitter gourd, gurmur leaves, jamun fruit and seed in type 2 diabetic patients. J Clin Diagn Res 2007;1: 511-520.
4. Yadav R, Tiwari P, Dhanaraj E. Risk factors and complications of type 2 diabetes in Asians. Curr Res Information Pharmaceut Sci 2008;9: 8-12.
5. Fowler MJ. Diabetes Treatment, Part 2: Oral agents for glycemic management. Clin Diabetes 2007;25: 131-134.
6. Valiathan MS. Healing plants. Curr Sci 1998;75: 1122.
7. Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 2002;81: 81-100.
8. Dineshkumar B, Mitra A, Manjunatha M. In vitro and in vivo studies of anti-diabetic Indian medicinal plants: A review. J Herbal Med Toxicol 2009;3: 9-14.
9. Patwardhan B, Vaidya ADB, Chorghade M. Ayurveda and natural products drug discovery. Curr Sci 2004;86: 789-799.
10. Said O, Fulder S, Khalil K, Azaizeh H, Kassis E, Saad B. Maintaining a physiological blood glucose level with 'Glucolevel', a combination of four anti-diabetes plants in the traditional Arab herbal medicine. Evid Based Complement Alternat Med 2007;5: 421-428.
11. Masibo M, He Q. Mango bioactive compounds and related nutraceutical properties- A review. Food Rev Int 2009;25: 346-370.
12. Bhatia VK, Ramanathan JD, Seshadri TR. Constitution of Mangiferin. Tetrahedron 1967;23: 1363-1368.
13. Choi TH, Hwang IK, Yi SS, Ki-Yeon Y, Lee CH, Hyung-cheul S, Yoon YS, Moo-Ho W. Effects of streptozotocin-induced type 1 diabetes on cell proliferation and neuronal differentiation in the dentate gyrus; Correlation with memory impairment. The Koeran J Anat 2009;42: 41-48.
14. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998;47: 224-229.
15. Hansawasdi C, Kawabata J, Kasai T. α- amylase inhibitors from Roselle (Hibiscus sabdariffa Linn.) tea. Biosci Biotechnol Biochem 2000;64: 1041-1043.
16. Pistia-Brueggeman G, Hollingsworth RI. A preparation and screening strategy for glycosidase inhibitors. Tetrahedron 2001;57: 8773-8778.
17. Temme Eh, Vaqn HPG, Schouten EG, Kesteloot H. Effect of plant sterol-enriched spread on serum lipids and lipoproteins in middly hypercholesterolaemic subjects. Acta Cardiology 2002;57: 111-115.
18. Bainton D, Miller NE, Botton CH, Yarnell JWG, Suretman PM, Baker IA. Plasma triglycerides and high density lipoprotein cholesterol as predictors of ischemic heart disease in British man. Br Heart J 1992;68: 60-66.
19. EI-harzmi MA, Warsy AS. Evaluation of serum cholesterol and triglyceride level in 1-6- year -old Saudi children. J Trop Pediatr 2001;47: 181-185.
20. Ravi K, Rajasekaran S, Subramanian S. Antihyperlipidemia effect of Eugenia Jambolana seed kernel on streptozotocin induced diabetes in rats. Food chem Toxicol 2005;43: 1433-1439.
21. Aderibigbe AO, Emudianughe TS, Lawal BAS. Evaluation of anti-diabetic action of Mangifera indica in mice. Phytother Res 2001;15: 456-458.
22. Martinez G, Giuliani A, Leon OS, Perez G, Nunez-Selles AJ. Effects of Mangifera indica L extract (QF808) on protein and hepatic lipoperoxidation. Phytother Res 2001;15: 581-585.
23. Beltz LA, Bayer DK, Moss AL, Simet IM. Mechanisms of cancer prevention by green and black tea polyphenols, Anticancer Agents Med Chem 2006;6: 389-406.
24. Ichiki H, Miura T, Kubo M, Ishihara E, Komatsu Y, Tanigawa K, Okada M. New antidiabetic compounds, mangiferin and its glucoside. Biol Pharm Bull 1998;21: 1389-1390.
25. Muruganandan S, Srinivasan K, Gupta S, Gupta PK, Lal J. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin in diabetic rats. J Ethnopharmacol 2005;97: 497-501.
26. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose-Fatty acid cycle, its role of in insulin sensitivity and metabolic disturbances in diabetic mellitus. Lancet 1963;1: 785-789.
27. David SH, Bell MB. Type 2 diabetes mellitus: What is the optimal treatment regimen? Am J Med 2004;116: 23-29.
28. McCue P, Vattem D, Shetty K. Inhibitory effect of clonal oregano extracts against porcine pancreatic amylase in vitro. Asia Pac J Clin Nutr 2004;13: 401-408
29. Cholbi MR, Paya M, Alcaraz MJ. Inhibitory effect of phenolic compounds on CCL4-induced microsomal lipid peroxidation. Experientia 1991;47: 195-199.
30. Sanchez GM, Re L, Giuliani A, Nunez-Selles AJ, Davison GP, Leon-Hernandez OS. Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacol Res 2000;42: 565-573